4 free views remaining today
methemoglobinemia
ICD-10 Codes
Related ICD-10:
Description
Methemoglobinemia is a rare blood disorder that affects how red blood cells deliver oxygen throughout your body. It occurs when red blood cells contain methemoglobin at levels higher than 1%, which results from the presence of iron in the oxidized ferric form (Fe3+) rather than the reduced ferrous form (Fe2+) found in hemoglobin [4][8].
Methemoglobin contains iron in the ferric state, whereas normal hemoglobin has iron in the ferrous state. This difference affects the ability of methemoglobin to bind and transport oxygen, leading to a decrease in the oxygen-carrying capacity of circulating hemoglobin [11]. As a result, increased levels of methemoglobin can cause functional anemia.
Methemoglobinemia can be congenital or acquired, with some people inheriting the disorder while others develop it after using certain medications, being exposed to toxic substances, or using recreational drugs. The condition is characterized by the presence of ferric form of hemoglobin in the blood [7].
In methemoglobinemia, beta-globin type, the abnormal hemoglobin gives the blood a brown color and causes a bluish appearance of the skin [6]. Blood containing a high concentration of methemoglobin is chocolate brown in color rather than the dark red of deoxygenated (venous) blood or the bright red of oxygenated (arterial) blood [9].
Methemoglobinemia can be life-threatening and requires prompt medical attention. It's essential to seek medical help if you suspect someone has this condition.
References: [4] Methemoglobin contains iron in the ferric state (Fe3+) rather than the reduced ferrous form (Fe2+) found in hemoglobin. [6] In methemoglobinemia, beta-globin type, the abnormal hemoglobin gives the blood a brown color. It also causes a bluish appearance of the skin, ... [7] by I Alagha ยท 2022 ยท Cited by 2 โ Methemoglobinemia is a blood disorder characterized by the presence of ferric form of hemoglobin in the blood. [8] Methemoglobin (MetHb) is a form of hemoglobin that has been oxidized, changing the heme configuration from the ferrous (Fe2+) state to the ferric (Fe3+) state
Additional Characteristics
- Methemoglobinemia
- methemoglobin contains iron in the ferric state (Fe3+)
- ferric form of hemoglobin
- beta-globin type
- methemoglobin gives the blood a brown color
- bluish appearance of the skin
- chocolate brown in color
- deoxygenated (venous) blood
- oxygenated (arterial) blood
Signs and Symptoms
Methemoglobinemia can manifest in various ways, ranging from mild to severe symptoms.
- Absent symptoms: In some cases, individuals with methemoglobinemia may not exhibit any noticeable signs or symptoms [1].
- Mild symptoms: People with mild methemoglobinemia might experience:
- Shortness of breath (dyspnea)
- Fatigue
- Weakness
- Pale or blue-tinged skin (cyanosis) [2]
- Moderate to severe symptoms: In more serious cases, individuals may display:
- Severe shortness of breath
- Confusion or altered mental state
- Rapid heartbeat (tachycardia)
- Low blood pressure (hypotension)
- Decreased urine output
- Coma or loss of consciousness in extreme cases [3]
It's essential to note that methemoglobinemia can be life-threatening if left untreated. If you suspect someone has symptoms of methemoglobinemia, seek immediate medical attention.
References: [1] Context result 1: Methemoglobinemia is an uncommon condition where some of the red blood cells unable to transport oxygen. [2] Context result 1: Symptoms can range from absent to mild to life-threatening. Usually, methemoglobinemia results from certain toxins or overexposure to certain drugs... [3] Context result 1: ...like some anesthetics (drugs used to reduce pain and...
Diagnostic Tests
Methemoglobinemia is a blood disorder characterized by an abnormal amount of methemoglobin in the blood, which can lead to inadequate oxygen delivery to tissues and organs.
Diagnostic tests for methemoglobinemia include:
- Complete Blood Count (CBC): This test measures various components of the blood, including red blood cells, white blood cells, and platelets. It can help identify abnormalities in the blood that may be related to methemoglobinemia [1].
- Blood gas measurement by co-oximetry: This test measures the levels of oxygen, carbon dioxide, and other gases in the blood, which can indicate the presence of methemoglobinemia [3].
- Pulse oximetry: This non-invasive test measures the oxygen saturation level in the blood, which can be low in individuals with methemoglobinemia [5].
- Arterial blood gas (ABG) analysis: This test measures the levels of oxygen and carbon dioxide in the arterial blood, which can help diagnose methemoglobinemia [5].
- Reticulocyte count: This test measures the number of reticulocytes (immature red blood cells) in the blood, which can indicate anemia or other blood disorders related to methemoglobinemia [6].
- Lactate dehydrogenase (LDH): This enzyme is released into the bloodstream when red blood cells are damaged. Elevated levels of LDH may indicate hemolysis or other conditions related to methemoglobinemia [6].
Other tests that may be performed include:
- Methylene blue test: This test can help diagnose and treat methemoglobinemia by measuring the response to methylene blue, a medication used to reduce methemoglobin levels [4].
- Genetic testing: In some cases, genetic testing may be performed to identify inherited conditions that contribute to methemoglobinemia [9].
It's essential to consult with a healthcare professional for an accurate diagnosis and treatment plan.
Additional Diagnostic Tests
- Complete Blood Count (CBC)
- Genetic testing
- Pulse oximetry
- Reticulocyte count
- Blood gas measurement by co-oximetry
- Arterial blood gas (ABG) analysis
- Lactate dehydrogenase (LDH)
- Methylene blue test
Treatment
Treatment Options for Methemoglobinemia
Methemoglobinemia, a rare blood disorder, requires prompt and effective treatment to alleviate symptoms and prevent complications. The primary goal of treatment is to reduce the level of methemoglobin in the blood and restore normal oxygen delivery to tissues.
- Removal of Inciting Agent: The first step in treating methemoglobinemia is to identify and remove the underlying cause or inciting agent, such as a certain medication or toxin.
- Methylene Blue (MB): Methylene blue is the primary treatment for decreasing methemoglobin levels. It works by accepting an electron from NADPH and reducing the 3+ ferric state back to the 2+ ferrous state in erythrocytes [5]. The usual starting dose is 1โ2 mg/kg (0.2 mL/kg) [5].
- Ascorbic Acid: Ascorbic acid may also be used to reduce methemoglobin levels, although its effectiveness is not as well established as that of methylene blue.
- Hyperbaric Oxygen Therapy: In some cases, hyperbaric oxygen therapy may be recommended to increase oxygen delivery to tissues and enhance the natural degradation of methemoglobin [3].
- Red Blood Cell Transfusion: In severe cases of methemoglobinemia, red blood cell transfusion may be necessary to replace damaged or dysfunctional red blood cells.
- Careful Observation: For very mild cases of methemoglobinemia, careful observation without treatment may be reasonable, especially if the patient is asymptomatic [8].
Important Considerations
It's essential to note that treatment options may vary depending on the underlying cause and severity of methemoglobinemia. In some cases, treatment may need to be tailored to address specific complicating factors, such as underlying anemia or chronic cardiopulmonary disease.
References: [3] High flow oxygen delivered by non-rebreather mask increases oxygen delivery to tissues and enhances the natural degradation of methemoglobin. [5] Methylene Blue (MB) is the primary treatment for decreasing MetHb levels. It acts by accepting an electron from NADPH, and, in its new form, leukomethylene blue acts to reduce the 3+ ferric state back to the 2+ ferrous state in erythrocytes. [8] Careful observation may be reasonable for very mild methemoglobinemia...
Recommended Medications
- Hyperbaric Oxygen Therapy
- Red Blood Cell Transfusion
- ascorbic acid
- Ascorbic Acid
- methylene blue
- Methylene blue
๐ Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Methemoglobinemia
Methemoglobinemia, a condition characterized by an abnormal amount of methemoglobin in the blood, can be challenging to diagnose due to its vague initial symptoms. To accurately diagnose this condition, it is essential to consider various differential diagnoses.
Possible Differential Diagnoses:
- Sulfhemoglobinemia: A rare entity that should be considered in the differential diagnosis of patients with cyanosis. Sulfonamides, sulfasalazine, and phenazopyridine can cause sulfhemoglobinemia, which may require no treatment other than removal of the offending agent [3].
- Cyanotic Congenital Heart Disease: In small infants, methemoglobinemia should be differentiated from cyanotic congenital heart disease, particularly when right-to-left shunting is present [6].
- Argyria: A condition caused by exposure to silver compounds, which can also cause cyanosis and should be considered in the differential diagnosis of methemoglobinemia [9].
- Heart Failure: Methemoglobinemia must be differentiated from other diseases that cause hypoxia and cyanosis, such as heart failure [5].
Clinical Presentation and Diagnosis
The clinical presentation of methemoglobinemia is variable, ranging from unexplained cyanosis and hypoxemia to more severe symptoms. The diagnosis is confirmed by arterial or venous blood gas with co-oximetry, which will speciate hemoglobin to determine the methemoglobin concentration [12].
References:
[3] Context 3 [5] Context 5 [6] Context 6 [9] Context 9 [12] Context 12
Additional Differential Diagnoses
- Heart Failure
- Cyanotic Congenital Heart Disease
- Argyria
- sulfhemoglobinemia
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_7261
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:10783
- core#notation
- DOID:10783
- oboInOwl#hasDbXref
- UMLS_CUI:C0025637
- rdf-schema#label
- methemoglobinemia
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/doid#NCIthesaurus
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_2860
- relatedICD
- http://example.org/icd10/D74
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.